1. Home
  2. GRFS vs VICR Comparison

GRFS vs VICR Comparison

Compare GRFS & VICR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.71

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Logo Vicor Corporation

VICR

Vicor Corporation

HOLD

Current Price

$200.38

Market Cap

7.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
VICR
Founded
1940
1981
Country
Spain
United States
Employees
23800
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.6B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
GRFS
VICR
Price
$8.71
$200.38
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$10.15
$132.50
AVG Volume (30 Days)
608.0K
690.3K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
1764.29
EPS
N/A
2.61
Revenue
N/A
$452,701,000.00
Revenue This Year
$5.33
$17.33
Revenue Next Year
$6.50
$14.44
P/E Ratio
$18.67
$76.83
Revenue Growth
N/A
26.08
52 Week Low
$6.19
$38.93
52 Week High
$11.14
$209.53

Technical Indicators

Market Signals
Indicator
GRFS
VICR
Relative Strength Index (RSI) 39.04 68.41
Support Level $8.66 $44.52
Resistance Level $9.11 N/A
Average True Range (ATR) 0.27 15.83
MACD -0.08 2.88
Stochastic Oscillator 27.18 90.82

Price Performance

Historical Comparison
GRFS
VICR

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About VICR Vicor Corporation

Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.

Share on Social Networks: